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Abstract
Genus Enterovirus (Family Picornaviridae,) consists of twelve species divided into genetically diverse types by their capsid
protein VP1 coding sequences. Each enterovirus type can further be divided into intra-typic sub-clusters (genotypes). The
aim of this study was to elucidate what leads to the emergence of novel enterovirus clades (types and genotypes). An
evolutionary analysis was conducted for a sub-group of Enterovirus C species that contains types Coxsackievirus A21 (CVA-
21), CVA-24, Enterovirus C95 (EV-C95), EV-C96 and EV-C99. VP1 gene datasets were collected and analysed to infer the
phylogeny, rate of evolution, nucleotide and amino acid substitution patterns and signs of selection. In VP1 coding gene,
high intra-typic sequence diversities and robust grouping into distinct genotypes within each type were detected. Within
each type the majority of nucleotide substitutions were synonymous and the non-synonymous substitutions tended to
cluster in distinct highly polymorphic sites. Signs of positive selection were detected in some of these highly polymorphic
sites, while strong negative selection was indicated in most of the codons. Despite robust clustering to intra-typic
genotypes, only few genotype-specific ‘signature’ amino acids were detected. In contrast, when different enterovirus types
were compared, there was a clear tendency towards fixation of type-specific ‘signature’ amino acids. The results suggest
that permanent fixation of type-specific amino acids is a hallmark associated with evolution of different enterovirus types,
whereas neutral evolution and/or (frequency-dependent) positive selection in few highly polymorphic amino acid sites are
the dominant forms of evolution when strains within an enterovirus type are compared.
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Introduction
Enteroviruses (genus Enterovirus, family Picornaviridae) are small
non-enveloped positive strand RNA viruses with icosahedral
capsid symmetry. Enteroviruses are classified to twelve species,
Enterovirus A to H, J and Rhinovirus A to C [1]. Seven of the species,
Enterovirus A to D (formerly named Human enterovirus A to D) and
Rhinovirus A to C (formerly named Human rhinovirus A to C) are
known to infect humans. Enteroviruses are associated with a
variety of clinical diseases, such as aseptic meningitis, encephalitis,
paralytic disease, respiratory infections, and acute haemorrhagic
conjunctivitis (AHC) although most enterovirus infections are sub-
clinical [2]. Enteroviruses are transmitted mostly via fecal-oral and
respiratory routes.
Enterovirus genome contains approximately 7500 nucleotides.
The genome consists of a single open reading frame (ORF) that is
flanked by 59 end and 39 end untranslated regions (59UTR and
39UTR). The ORF is translated to a single polypeptide that is
autocatalytically cleaved to P1, P2 and P3 polyproteins. The P1
polyprotein is further cleaved to capsid proteins VP4 to VP1,
whereas P2 and P3 are cleaved to non-structural proteins 2A–2C
and 3A–3D, respectively.
On the basis of the capsid coding P1 region, enteroviruses form
genetically highly diverse types that are equivalent to serotypes
defined by antigenic properties [3,4]. Currently, enterovirus types
are defined by the sequence divergences in the capsid protein VP1
coding region. Members of the same type have more than 75%
nucleotide (nt) and more than 88% amino acid (aa) similarities in
the VP1 region [3,5]. Correspondingly, the strains that have less
than 70% nucleotide and 85% amino acid similarities are classified
to different types. Empirical observations suggest that, in general,
the pair wise sequence similarities between enterovirus strains do
not form a continuum across the type designations, but rather the
members of different types are clearly separated [3]. However,
divergent strains that have pairwise nt/aa similarities in the ‘grey-
zone’ of current typing (i.e. 70–75% nt and/or 85–88% aa
similarity), such as some CVA-24 and EV-C99 strains, are
detected regularly [5].
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Although the current typing standard is of great practical value,
little is known about the evolutionary processes behind the
observed sequence similarity patterns. Likewise, although the
implementation of molecular methods for genetic enterovirus
typing has led to the discovery of a large number of novel
enterovirus types (reviewed in [6]), much less is known about
evolutionary processes behind the formation of the enterovirus
types.
The aim of this study was to elucidate the evolutionary processes
behind the origin and emergence of novel enterovirus clades (types
and genotypes).The clearly resolved hierarchical phylogeny of EV-
C species [5,7,8] provides an opportunity to study the evolutionary
patterns that have led to the emergence of novel enterovirus
clades. In this study, an evolutionary analysis was conducted for a
sub-group of EV-C species that contains types CVA-21, CVA-24,
EV-C95, EV-C96 and EV-C99. Of these enterovirus types, CVA-
21 induces mainly mild respiratory infections [9,10], whereas EV-
C96, EV-C99 and some of the (prototype-like) CVA-24 strains
have been isolated from faecal samples of healthy individuals and
patients with paralytic disease [5,8,11–20]. A distinct lineage of
CVA-24, so-called variant strains (CVA-24v), induce acute
haemorrhagic conjunctivitis (AHC) [21] and are transmitted via
direct or indirect contact with eye-secretions [2]. EV-C95 is a
recently discovered enterovirus type (Helene Norder unpublished
[1]. So far, only two strains of this type have been characterized
[17]. Parallel datasets of VP1 sequences were collected and
analysed to infer the phylogenetic structure, rate of evolution,
nucleotide and amino acid substitution patterns and signs for
selection in the VP1 coding region.
Material and Methods
Ethics statement
The virus samples were collected with the consent of The
Institutional Review Board of National Institute for Health and
Welfare (THL), the Ethics Committee of M.P. Chumakov Institute
of Poliomyelitis and Viral Encephalitides of Russian Academy of
Medical Sciences and the Ethical Committee of the Minsk
Municipality and analyzed anonymously. The sewage samples
were obtained from Viikki wastewater treatment plant in Helsinki,
Finland. No specific permission was required for the surveillance
for enteroviruses from sewage. The field studies did not involve
endangered or protected species.
Viruses
The virus strains isolated in this study are listed in Table 1.
Virus strains were isolated from sewage samples collected during
environmental surveillance for polioviruses in Finland using a two-
phase concentration method [22]. In addition, clinical enterovirus
isolates sent to the national enterovirus reference laboratory
(National Institute for Health and Welfare, THL) from other
Finnish laboratories were included in the study [23]. The rest of
the virus strains were received as untypeable nonpolio enterovi-
ruses (NPEV) from a number of National Polio Laboratories of the
WHO Polio Laboratory Network supporting the Global Poliovirus
Eradication Initiative. Human rhabdomyosarcoma (RD), human
colorectal adenocarcinoma (CaCo-2), human cervical carcinoma
(HeLa) and green monkey kidney (GMK) cell lines were used for
virus isolation.
Partial VP1 RT-PCR and sequencing
Viral RNA was extracted from infected cell cultures with
RNeasy Total RNA kit (Qiagen, Hilden, Germany) or E.Z.N.A.
Total RNA Kit Omega (Bio-Tek Inc., Doraville, GA, USA)
according to the manufacturer’s instructions. RT-PCR was carried
out as described previously [24] using primers 292 and 222. PCR
amplicons were purified with the QIAquick gel extraction kit
(Qiagen). Sequencing reactions with BigDye Terminator cycle
sequencing ready reaction kit v3.1 (Life Technologies, Carlsbad,
CA, USA) and sequencing with ABI3730 Automatic DNA
Sequencer (Life Technologies) were performed by the Institute
for Molecular Medicine Finland (FIMM) Sequencing Laboratory.
The electropherograms were analysed using Geneious Pro 6.0
software (Biomatters Ltd, Auckland, New Zealand, http://www.
geneious.com).
Sequence dataset collection
Two parallel datasets were constructed from the sequences. The
first dataset contained partial VP1 sequences characterized in this
study (N=72) (Table 1), the overlapping CVA-21, CVA-24, EV-
C95, EV-C96 and EV-C99 sequences retrieved from the
GenBank and the overlapping sequences of the prototype strains
of other EV-C types. Altogether this dataset consisted of 264
sequences. The consensus alignment of partial VP1 dataset
consisted of 343 nucleotide sites. The second dataset contained
the strain CVA-24-FIN05-1-7920 and all complete CVA-21,
CVA-24, EV-C95, EV-C96 and EV-C99 VP1 sequences found in
the GenBank (27.2.2013). The complete VP1 dataset consisted of
97 strains. The consensus alignment of this dataset contained 927
nucleotides. To relieve computational demands and correct data
collection bias, only one representative sequence from the clusters
that shared more than 99% similarity with each other was
included in the analysis.
Sequence analysis
The sequences were aligned using ClustalW algorithm (for
codons) implemented in MEGA version 5.05 [25] followed by
manual refinement. Phylogenetic trees were constructed using
neighbor-joining (NJ) method implemented in MEGA version
5.05 and Bayesian Monte Carlo Markov Chain (MCMC) method
implemented in BEAST version 1.7.4 [26]. For NJ-trees, bootstrap
resampling with 1000 replicates was conducted. Various substitu-
tion models including Tamura-Nei (TN93) [27] and general time
reversible (GTR) [28] were utilized.
The rates of evolution and divergence times of the virus lineages
were estimated using Bayesian MCMC method implemented in
BEAST version 1.7.4 [26]. Different molecular clock and
demographic models were compared by calculating the marginal
likelihoods of the data [29]. Bayes factors (BF) were calculated for
each pair of models with Tracer 1.5 [30]. The uncorrelated
relaxed molecular clock approach (log-normal distribution fitted
the data significantly better than strict clock or the relaxed
molecular clock approach with exponential distribution (log
BF.400). The Bayesian skyline demographic model fitted the
data significantly better than constant or exponential models (log
BF.400). Therefore, the analyses were performed using a relaxed
molecular clock model (the uncorrelated log-normal distributed
model) [31], GTR model of substitution and Bayesian skyline
demographic model. The Bayesian analyses were run for 100
million states and sampled every 1000 states. The analyses were
carried out on the Bioportal server, University of Oslo (www.
bioportal.uio.no) [32] and in CSC – IT Center for Science Ltd.
(Espoo, Finland). The analyses were run in duplicate and the log-
files were combined to increase the effective sample size. Posterior
probabilities were calculated with a burn-in of 10 million states
and checked for convergence using Tracer version 1.5. [30].
Codon-specific synonymous (dS) to non-synonymous (dN) rates
were estimated using single likelihood ancestor counting (SLAC),
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Table 1. The strains sequenced in this study.
Strain Collection Date Country Sample Type
CVA-21-EST06-E1783-20171_28-Feb-2006 28-Feb-2006 Estonia Sewage
CVA-21-FIN03-862-36252 2003 Finland Stool
CVA-21-FIN06-E1906-28163_27-Sep-2006 27-Sep-2006 Finland Sewage
CVA-21-FIN06-E2006-32088_19-Dec-2006 19-Dec-2006 Finland Sewage
CVA-21-FIN06-EV06-34A-30796_14-Nov-2006 14-Nov-2006 Finland Stool
CVA-21-LVA03-756_5-Mar-2003 5-Mar-2003 Latvia
CVA-21-RUS01-15341_4-Jul-2001 4-Jul-2001 Russia Stool
CVA-21-SVK05-E1571_Skalica_17-Feb-2005 17-Feb-2005 Slovak Republic Sewage
CVA-21-SVK07-E2058_ Dunajska Streda_10-Jan-2007 10-Jan-2007 Slovak Republic Sewage
CVA-24-AUT05-1600_12-Apr-2005 12-Apr-2005 Austria
CVA-24-FIN02-671 2002 Finland Sewage
CVA-24-FIN04-EV04-27A-2124 2004 Finland (India) Stool
CVA-24-FIN04-EV04-34A-3787 2004 Finland (India) Stool
CVA-24-FIN05-1-7920-2005 2005 Finland (China) Stool
CVA-24-FIN05-1663-13794_18-Oct-2005 18-Oct-2005 Finland Stool
CVA-24-FIN05-EV05-17A_31-Oct-2005 31-Oct-2005 Finland (China) Stool
CVA-24-FIN06-1869-25202_6-Sep-2006 6-Sep-2006 Finland Stool
CVA-24-FIN06-EV06-32A-30807_24-Oct-2006 24-Oct-2006 Finland Stool
CVA-24-FIN06-EV07-2A-29392_18-Dec-2006 18-Dec-2006 Finland Stool
CVA-24-FIN07-EV07-12A-33320_15-May-2007 15-May-2007 Finland Stool
CVA-24-FIN07-EV07-13A-33425_28-May-2007 28-May-2007 Finland Stool
CVA-24-FIN07-EV07-25A-37012_22-Aug-2007 22-Aug-2007 Finland Stool
CVA-24-FIN07-EV07-26A-37474_30-Aug-2007 30-Aug-2007 Finland Stool
CVA-24-FIN07-EV07-42A-51242_2007 2007 Finland Stool
CVA-24-FIN07-EV08-1A-51415_18-Dec-2007 18-Dec-2007 Finland Stool
CVA-24-FIN08-EV08-28A-59927_10-Oct-2008 10-Oct-2008 Finland Stool
CVA-24-FIN08-EV08-3A-51551_30-Jan-2008 30-Jan-2008 Finland Stool
CVA-24-FIN09-2996-72114_20-May-2009 20-May-2009 Finland (India) Stool
CVA-24-FIN09-3137-78084_23-Oct-2009 23-Oct-2009 Finland Stool
CVA-24-FIN09-3140-78104_22-Oct-2009 22-Oct-2009 Finland Stool
CVA-24-FIN09-EV09-11B-70968_14-May-2009 14-May-2009 Finland Stool
CVA-24-FIN09-EV09-12B-70971_5-May-2009 5-May-2009 Finland Stool
CVA-24-FIN09-EV09-14A-72174_15-Jun-2009 15-Jun-2009 Finland Stool
CVA-24-FIN09-EV09-7A-70636_27-Feb-2009 27-Feb-2009 Finland Stool
CVA-24-FIN10-E3319-A341_23-Mar-2010 23-Mar-2010 Finland Sewage
CVA-24-FIN10-EV10-23B-91082_30-Aug-2010 30-Aug-2010 Finland Stool
CVA-24-FIN10-EV10-2B_2-Mar-2010 2-Mar-2010 Finland Stool
CVA-24-LVA03-757_19-Jun-2003 19-Jun-2003 Latvia
CVA-24-RUS-00-14038_21-Nov-2000 21-Nov-2000 Russia Stool
CVA-24-RUS-01-14455_14-Feb-2001 14-Feb-2001 Russia Stool
CVA-24-RUS-TKM01-14868_10-Mar-2001 10-Mar-2001 Russia (Turkmenistan) Stool
CVA-24-RUS-KGZ01-15071_18-Jun-2001 18-Jun-2001 Russia (Kyrgyzstan) Stool
CVA-24-RUS-UZB01-15213_20-Jun-2001 20-Jun-2001 Russia (Uzbekistan) Stool
CVA-24-RUS-TKM01-15327_23-Jun-2001 23-Jun-2001 Russia (Turkmenistan) Stool
CVA-24-RUS-KGZ01-15876_20-Jul-2001 20-Jul-2001 Russia (Kyrgyzstan) Stool
CVA-24v-FIN07-EV07-20A-34537_15-Jul-2007 15-Jul-2007 Finland Conjunctival secretion
CVA-24v-FIN07-EV07-22B_13-Aug-2007 13-Aug-2007 Finland Stool
EV-C96-FIN08-EV08-10A-55557_14-May-2008 14-May-2008 Finland Stool
EV-C96-FIN09-2983-70820_28-May-2009 28-May-2009 Finland Stool
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fixed effects likelihood (FEL), [33] and FUBAR [34] methods
implemented in Datamonkey website (www.datamonkey.org) [35].
For this analysis, the nucleotide substitution model was selected
using model test implemented in the Datamonkey website and the
phylogenetic trees were reconstructed using the Neighbour-Joining
method.
The signatures of directional selection were sought using
McDonald–Kreitman test (MK-test) [36] implemented in DnaSP
v.5.10 [37] and modified MK-tests [38,39] implemented in The
standard and generalized MKT website (http://mkt.uab.es/mkt/)
[38] and Adapt-A-Rate v.1.0 software [40]. The MK-test
compares the ratio of fixed non-synonymous to synonymous
differences between two predefined groups and the ratio of
polymorphic non-synonymous to synonymous differences and
assumes that under neutral evolution these ratios should be equal.
In the modification by Egea et al., [38] the estimated number of
mutations instead of the number of sites in each class are counted.
The modification by Bhatt et al., [39] utilizes proportional
counting algorithm in which proportional fixation, polymorphic,
silent and replacement ‘‘site scores’’ are utilized instead of
unambiguously assigned numbers of sites in each class. The
modified MK-tests were run independently either including or
excluding potentially mildly deleterious low-frequency variants
(with ,0.05 frequency). The modified test by Bhatt et al., [39] was
also run using polymorphic (neutral) classes with frequencies 0-
0.50 [41] and 0.05-0.75 (i.e. excluding both potentially mildly
deleterious low-frequency variants and highly polymorphic sites
that are potentially under frequency-dependent antigenic selec-
tion).
The locations of amino acid substitutions were estimated with 3-
dimensional structure model of Coxsackievirus A21 pentamer
(PDB ID: 1Z7Z) [42] using Jmol [43].
GenBank accession numbers
The GenBank accession numbers for the sequenced strains are
KF128985 - KF129056.
Results
Phylogeny and sequence diversities of partial vp1
sequences
To gain insight into the evolution and epidemiology of
enterovirus VP1 coding sequences, partial VP1 coding regions of
six EV-C96 strains, 19 EV-C99 strains, nine CVA-21 strains, 36
CVA-24 strains and two CVA-24v strains that were isolated
during poliovirus surveillance were sequenced and subjected to
phylogenetic analysis together with overlapping sequences re-
trieved from the GenBank (search 27.2.2013).
Consistently with the previous studies [5,7,44,45], in the VP1
coding region, all of the EV-C types clustered into three sub-
groups, which were designated here as A (CVA-1, CVA-19, CVA-
22, EV-C104, EV-C105, EV-109, EV-C116, EV-C117 and EV-
C118), B (EV-C95, EV-C96, EV-C99, CVA-21 and CVA-24) and
C (CVA-13, CVA-17, CVA-20, EV-C102, PV-1, PV-2 and PV-3)
(Fig. 1), with the branching order of sub-group A diverging first
from the common ancestor of sub-groups B and C. CVA-11
grouped together with the strains of sub-groups B or C depending
on the method of phylogenetic tree construction.
Table 1. Cont.
Strain Collection Date Country Sample Type
EV-C96-FIN09-EV09-13B_5-May-2009 5-May-2009 Finland Stool
EV-C96-FIN09-EV09-9A-70153_24-Mar-2009 24-Mar-2009 Finland Stool
EV-C96-FIN10-EV10-3A-84622_27-Apr-2010 27-Apr-2010 Finland Stool
EV-C96-FIN12-EV12-11B_9-May-2012 9-May-2012 Finland Stool
EV-C99-FIN06-EV06-31B-30779_6-Nov-2006 6-Nov-2006 Finland Stool
EV-C99-FIN07-EV07-24A-37056_17-Aug-2007 17-Aug-2007 Finland Stool
EV-C99-FIN07-EV08-2A-51416_20-Dec-2007 20-Dec-2007 Finland Stool
EV-C99-FIN08-EV08-19A-56305_11-Aug-2008 11-Aug-2008 Finland Stool
EV-C99-FIN08-EV08-7A-55125_7-Apr-2008 7-Apr-2008 Finland Stool
EV-C99-RUS-TKM00-13831_8-Sep-2000 8-Sep-2000 Russia (Turkmenistan) Stool
EV-C99-SVK03-23-20226_7-Feb-2003 7-Feb-2003 Slovak Republic
EV-C99-SVK04-E1152-44722_19-May-2004 19-May-2004 Slovak Republic Sewage
EV-C99-FIN09-EV09-15A-72176_22-Jun-2009 22-Jun-2009 Finland Stool
EV-C99-FIN11-4266-10449_6-Oct-2011 6-Oct-2011 Finland Stool
EV-C99-FIN09-2991-70979_2-Jun-2009 2-Jun-2009 Finland (Nigeria) Stool
EV-C99-BLR00-32864-2000 2000 Republic of Belarus Stool
EV-C99-BLR00-32878-2000 2000 Republic of Belarus Stool
EV-C99-BLR00-32881-2000 2000 Republic of Belarus Stool
EV-C99-BLR00-32887-2000 2000 Republic of Belarus Stool
EV-C99-BLR00-33291-2000 2000 Republic of Belarus Stool
EV-C99-BLR00-33305-2000 2000 Republic of Belarus Stool
EV-C99-BLR00-33405-2000 2000 Republic of Belarus Stool
EV-C99-BLR00-33483-2000 2000 Republic of Belarus Stool
doi:10.1371/journal.pone.0093737.t001
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Figure 1. The phylogeny of partial VP1 sequences of EV-C species, including strains isolated in this study. The phylogenetic tree was
constructed from partial VP1 coding region (consensus alignment 343 nucleotides) of CVA-21 (red), CVA-24 (green), EV-C95 (yellow), EV-C96 (orange)
and EV-C99 (blue) strains and the prototype strains of other EV-C types. The strains sequenced in this study are indicated with black triangles. The tree
was constructed using the Neighbour-Joining method and the Tamura-Nei substitution model. The bootstrap support values were calculated for
1000 replicates. The bootstrap support values .70 are shown. The inset represents the same tree with EV-C subgroups A to C identified.
doi:10.1371/journal.pone.0093737.g001
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Within EV-C sub-group B, the phylogenetic analysis suggested
well-supported hierarchical branching orders. EV-C96 formed an
outgroup to the EV-C95/CVA-21/CVA-24/EV-C99 cluster,
suggesting that EV-96 has diverged first from a common ancestor
of EV-C sub-group B. This divergence has been followed by the
branching of the ancestor of EV-C95/CVA-21 from the ancestor
of CVA-24/EV-C99 and finally splitting of the ancestors of EV-
C95/CVA-21 and CVA-24/EV-C99 into distinct types. Each of
the types in EV-C sub-group B were further divided into intra-
typic sub-clusters (or genotypes) with robust (i.e. .70) bootstrap
support (Fig 1) or with high posterior probability (Fig 2). These
genotypes are designated with upper case letters in Figure 2.
Generally similar branching patterns were observed using both
NJ (Fig 1.) and the Bayesian MCMC methods (Fig 2). However,
there was slight variation in the intra-typic sub-clustering pattern
between the methods. In the NJ-tree, the non-AHC-causing CVA-
24 strains formed a loose paraphyletic group with low bootstrap
support (Fig 1), whereas in MCC tree, all CVA-24 strains formed a
monophyletic group with high posterior probability (Fig 2). Many
of the intra-typic clusters of EV-C96 and CVA-24 were detected in
the MCC-tree (Fig 2) but not in the NJ-tree (Fig. 2). These
tentative genotypes were designated as CVA-24-A to J and EV-
C96 A to C, respectively (Figure 2). The AHC-causing variant
strains of CVA-24 (CVA-24v) formed a monophyletic sub-cluster
with both methods. All sub-clusters of CVA-21 were highly
supported by both methods. However, a common ancestor for the
genotypes CVA-21-A and –B was suggested by the Bayesian
method only. For EV-C99 both methods suggested similar
branching pattern. In addition, both methods suggested a
common ancestor for the previously designated EV-C99 genotypes
B and C [17,46].
Representatives of all EV-C96 and EV-C99 intra-typic geno-
types and nearly all CVA-24 genotypes (excluding clusters
genotypes A, F and G) were detected in this study. For CVA-21,
all the strains sequenced in this study clustered to genotype C.
Most of the strains sequenced in this study showed no evidence of
geographic or temporal clustering. However, a distinct lineage of
EV-C99 was detected in December 2007, April 2008, August 2008
and June 2009 in Finland (Fig 3a). Likewise, a distinct lineage of
CVA-24 (designated as CVA-24-I in Fig 2) was detected
repeatedly between years 2003 and 2010 (and every year between
2006 and 2010) in Finland (Fig 3b). Another CVA-24 lineage was
detected in years 2007 and 2009 in Finland (Fig 3c). This lineage
was related to a strain isolated in Bangladesh in 2008 [19]. In
addition, eight strains of EV-C99 isolated in an orphanage in
Minsk, Belarus during an oral poliovirus vaccination study [47]
formed a separate cluster in the phylogenetic analysis (Fig 3d).
A wide variation in the nucleotide and amino acid sequences of
the VP1-coding region was observed within each of the EV-C sub-
group B types (Table 2) and, between some of the strains, the
intra-typic similarities exceeded the 75/85% nucleotide/amino
acid identity limit for classification into a single type. The inter-
typic nucleotide and amino acid similarities between EV-C99 and
CVA-24 were 68.0-81.3% and 78.8–94.9%, respectively. Thus, in
Figure 2. Maximum clade credibility tree of partial VP1
sequences of EV-C species, including strains isolated in this
study. The maximum clade credibility tree was constructed from
partial VP1 coding region (consensus alignment 343 nucleotides) of
CVA-21 (red), CVA-24 (green), EV-C95 (yellow), EV-C96 (orange) and EV-
C99 (blue) strains and the prototype strains of other EV-C types. The
phylogenetic tree was constructed using Bayesian MCMC method with
GTR model of substitution and Bayesian skyline demographic model.
Posterior probabilities are shown in each node.
doi:10.1371/journal.pone.0093737.g002
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agreement with the previous studies [5], although both of these
viruses formed clearly separated monophyletic groups, all pair wise
comparisons between the strains of these types did not reach the
limit of grouping into different types.
Codon-specific substitution patterns and selection
In order to elucidate the evolutionary forces leading to the
observed phylogeny, a second dataset that contained the strain
CVA-24-FIN05-1-7920 and all complete CVA-21, CVA-24, EV-
C95, EV-C96 and EV-C99 VP1 sequences found from the
GenBank (search 27.2.2013) was analysed. The major EV-C sub-
groups A, B and C, as well as the branching order within EV-C
sub-group B, were congruent with those observed in the partial
VP1 data (Fig 4). Representatives of all intra-typic genotypes of
designated using partial VP1 dataset, excluding CVA-24 geno-
types G to J, were included in this dataset. The range of intra and
inter-typic nucleotide and amino acid similarities were slightly
lower in the complete VP1 dataset compared to those observed in
the partial VP1 dataset (Table 2).
The VP1 consensus alignment of EV-C96, EV-C95, CVA-21,
CVA-24 and EV-C99 contained 309 codons. In comparison to
EV-C96, the VP1 amino-terminal domains of CVA-21, CVA-24,
EV-C95 and EV-C99 contained deletions of 9, 4, 9 and 5-6 amino
acids corresponding to sites 21-29 in the alignment. EV-C99
showed intra-typic differences in the length of the deletion, since
the strains of EV-C99 group A had a deletion of 5 amino acids
whereas the other strains of EV-C99 had deletions of 6 amino
acids. Furthermore, the amino acid sequences of EV-C99 group A
and group B/C were highly divergent in this region. The strains of
EV-C99 group A also had another deletion of a single amino acid
corresponding to site 152 in the consensus alignment. CVA-21
and EV-C95 had a deletion of two amino acids corresponding to
sites 103–104 in the consensus alignment.
Figure 3. Sub-trees of strains that showed geographic clustering. The phylogenetic trees were constructed from partial VP1 coding region
(343 nucleotides) using Neighbour-Joining method and the Tamura-Nei substitution model. Bootstrap values .70 are shown.
doi:10.1371/journal.pone.0093737.g003
Table 2. Nucleotide (lower left) and amino acid (upper-right) similarities (%) between VP1 sequences of EV-C sub-group B
serotypes.
EV-C96 EV-C95 CVA-21 EV-C99 CVA-24
Partial VP1 EV-C96 71.9/86.2 62.6–73.5 60.4–70.8 70.0–82.8 70.0–82.9
EV-C95 56.4–64.1 98.0/99.3 80.1–86.1 66.4–76.2 67.6–75.7
CVA-21 53.3–66.3 66.5–71.7 74.1/87.5 65.7–76.7 66.4–78.6
EV-C99 60.5–72.5 58.7–66.3 58.8–69.3 71.1/84.0 78.8–94.9
CVA-24 59.9–73.8 59.5–68.0 61.3–72.5 68.0–81.3 71.8/84.1
Complete VP1 EV-C96 75.3/89.3 70.1–71.8 66.4–70.8 72.9–80.9 71.5–77.4
EV-C95 61.5–64.5 98.0/99.3 82.9–84.2 73.7–77.5 73.8–77.2
CVA-21 61.0–65.8 68.3–71.5 76.1/91.9 72.7–76.8 73.2–78.5
EV-C99 65.1–71.5 64.2–67.5 64.2–69.9 73.1/86.1 80.4–88.7
CVA-24 63.6–70.5 64.3–68.7 65.1–70.5 69.8–75.9 75.0/88.2
Minimum nucleotide/amino acid similarity within each type is shown in the diagonal (bolded).
doi:10.1371/journal.pone.0093737.t002
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Codon-specific non-synonymous to synonymous substitution
frequencies were assessed using single likelihood ancestor counting
(SLAC), fixed effects likelihood (FEL) and FUBAR methods
available at the Datamonkey facility (www.datamonkey.org) [35].
The synonymous and non-synonymous substitution frequencies
and the normalized dS-dN estimated using FUBAR method are
shown in Fig 5. The analyses suggested that strong negative
selection was occurring over most of the codons of the VP1-coding
region in all of the types. However, elevated dN to dS ratios were
detected for some codons by all of the methods, and statistically
significant evidence for positive selection was suggested for codons
104 and 105 in EV-C96, codons 105 and 296 in EV-C99 and
codon 105 in CVA-24 by at least one of the methods (Table 3).
When the AHC-causing variant strains of CVA-24 (i.e. CVA-24v)
and other CVA-24 strains were treated as separate groups,
evidence for positive selection was detected in different sites (Fig 6).
Elevated dN/dS was detected in codons 25 and 150 for CVA-24v
and in codon 105 for non-AHC inducing CVA-24 (Table 3).
Notably, CVA-24v strains showed strict conservation of alanine at
site 105 (only one CVA-24v strain had aspartic acid in this site)
whereas the non-AHC-causing strains of CVA-24 had high amino
acid polymorphism (i.e. E, D, V, G, R, S, Q, N or T) in this site.
Generally, the codons with signs of positive selection were highly
polymorphic at amino acid level within the respective type
(Table 3). Parallel evolution was also commonly detected in these
sites (i.e. similar amino acid substitution had apparently occurred
independently in different genetic lineages).
Within each type, most of the non-synonymous substitutions
concentrated in distinct regions (Fig 5) that were most likely (on the
basis of CVA-21 structure [42]) located at the structurally
disordered N- and C-terminal regions and the loops between
beta-sheets (Figure S1). Although the codons with high rate of non-
synonymous substitutions overlapped partially between the types,
at several regions, there were differences between types both in the
location of polymorphic amino acid sites and the frequency of
amino acid substitutions in these sites. The disparities in the
locations of polymorphic sites between EV-C96, EV-C99 and
non-AHC causing CVA-24 strains were subtle, polymorphic sites
being often dislocated only by few amino acids, whereas more
pronounced differences were detected between CVA-21, CVA-
24v and other types. For example, the amino acid sites 223-230
were highly polymorphic among EV-C96, EV-C99 and non-AHC
causing CVA-24 strains but conserved completely within CVA-21
(LEGENTDA) and CVA-24v (LKDETVS). Notably, several
amino acid sites that were polymorphic among non-AHC causing
CVA-24 sites were conserved among CVA-24v strains. Such sites
included codons 22 (N, Q, K, S vs. Q), 103 (I, T, N, S, E vs. T),
172 (Q, T, I, R, K vs. R), 174 (A, N, T, K vs. T), 295 (N, D, S, A,
G, E vs. D), 296 (S, A, E, L, T vs. S) and 304 (A, E, N, K, T, S, D
vs. E).
Signs of directional selection between CVA-21, CVA-24, EV-
C95, EV-C96 and EV-C99 and between the intra-typic genotypes
within these enterovirus types were sought using McDonald-
Kreitman test (MK-test) [36] and modifications of this test [38,39].
Figure 4. The phylogeny of EV-C species VP1 gene. The
phylogenetic tree was constructed from complete VP1 coding region
(consensus alignment 927 nucleotides) of those CVA-21 (red), CVA-24
(green), EV-C95 (yellow), EV-C96 (orange) and EV-C99 (blue) strains, of
which a complete VP1 sequence was available (GenBank search
27.2.2013), and the prototype strains of other EV-C types. The tree
was constructed using the Neighbour-Joining method and the Tamura-
Nei substitution model. The bootstrap support values were calculated
for 1000 replicates. The bootstrap support values .70 are shown.
doi:10.1371/journal.pone.0093737.g004
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The results of the MK-tests are summarized in Table 4. The
numbers of sites/substitutions in each MK-test class for different
EV-types and intra-typic genotypes are shown in Tables S1–S6.
The MK-tests suggested significantly increased proportion of non-
synonymous mutations among the fixed sites for all inter-typic
comparisons. Likewise, the comparison between EV-C99 groups
A and B/C suggested statistically significant evidence of higher
than expected number of fixed non-synonymous substitutions
Figure 5. Codon-specific selection. The codon-specific differences between non-synonymous and synonymous rates (normalised dN-dS) (a,c,e,g)
and the codon specific posterior distribution means of the synonymous (alpha) and non-synonymous (beta) substitution rates (b,d,f,h) estimated
using FUBAR-method. Codons with statistically significant (posterior probability .0.9) evidence for positive selection are shown in red (a, c, e, g).
doi:10.1371/journal.pone.0093737.g005
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between these genotypes. In contrast, no consistent deviation from
neutrality was observed between intra-typic genotypes of EV-C96,
CVA-21 and CVA-24 (Table 4).
Evolutionary rates
The rates of evolution and times of most recent common
ancestors (tMRCA) were estimated for both the complete and the
partial VP1 datasets using Bayesian MCMC method with relaxed
molecular clock (Table 5). The estimated rates of substitution were
1.97261023 (high-probability distribution [95% HPD] range
1.097–2.90361023) and 2.83961023 (95% HPD range 2.177–
3.50961023) substitutions/site/year for complete and partial VP1
datasets, respectively. The corresponding estimated rates of
evolution and tMRCAs for each type in EV-C sub-cluster B are
shown in the Table 5.
Discussion
In order to elucidate the evolutionary processes that may lead to
emergence of novel enterovirus types or genotypes, we determined
evolutionary patterns of EV-C species sub-group B (i.e. strains of
CVA-21, CVA-24, EV-C95, EV-C96 or EV-C99) VP1 gene using
sequence data collected during entero/poliovirus surveillance
together with sequence data retrieved from the GenBank.
Figure 6. Codon-specific selection in CVA-24v and non-AHC-causing strains of CVA-24. The codon-specific differences between non-
synonymous and synonymous rates (normalised dN-dS) (a,c) and the codon specific posterior distribution means of the synonymous (alpha) and non-
synonymous (beta) substitution rates (b,d) estimated using FUBAR-method. Codons with statistically significant (posterior probability .0.9) evidence
for positive selection are shown in red (a, c).
doi:10.1371/journal.pone.0093737.g006
Table 3. The VP1 codons that had signs of positive selection.
Normalized dN-dS Amino acid composition of the site
Type Codon SLAC FEL FUBAR
EV-C96 104 0.89 2.43 0.89 S, T, N, A, V, L, M
105 1.86 3.84 0.76 E, S, T, A, V, I,
EV-C99 105 0.36 3.30 2.57 R, K, E, S, T, N, Q, G, P, I, A, V
296 0.42 4.57 1.73 S, T, A
CVA-24 105 0.29 0.57 0.52 R, K, D, E, S, T, N, Q, G, A, V
CVA-24 (non-AHC) 105 2.63 1.04 0.45 R, K, D, E, S, T, N, Q, G, A, V
CVA-24v 25 1.76 3.36 0.21 H, S, P, L
150 2.03 1.76 0.32 S, T, A
The normalized dN-dS values with statistically significant evidence of positive selection are shown in boldface. The significance level (p-value) of 0.1 or posterior
probability of 0.9 were used as confidence limits.
doi:10.1371/journal.pone.0093737.t003
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Table 4. The summary of the results of MK-tests.
Modified MK (Egea et al., 2008) Modified MK (Bhatt et al., 2010)
Neutral site threshold frequency
Clusters compared (N of strains in cluster)
MK (McDonald &
Kreitman 1991)
low-frequency (,5%)
variants excluded 0-,1 ,0.50 0.05–0.75
EV-C96 (12) CVA-21 (16) *** *** *** *** *** ***
EV-C96 (12) CVA-24 (42) *** *** *** *** *** ***
EV-C96 (12) EV-C99 (24) *** *** *** *** *** ***
EV-C96 (12) EV-C95 (2) *** *** *** * * *
CVA-21 (16) CVA-24 (42) *** *** *** *** *** ***
CVA-21 (16) EV-C99 (24) *** *** *** *** *** ***
EV-C95 (2) CVA-21 (16) *** *** *** *** *** ***
EV-C95 (2) EV-C99 (24) *** *** *** *** *** ***
EV-C95 (2) CVA-24 (42) *** *** *** *** *** ***
EV-C99 (24) CVA-24 (42) *** *** *** *** *** ***
EV-C96-A (2) EV-C96-B (10) - - - - - -
EV-C96-A (2) EV-C96-B1 (3) - - - - - -
EV-C96-A (2) EV-C96-B2 (7) - - - - - -
EV-C96-B1 (3) EV-C96-B2 (7) - - - - - -
CVA-21-A (2) CVA-21-B (4) - - - - - -
CVA-21-A (2) CVA-21-C (10) - - - - - -
CVA-21-B (4) CVA-21-C (10) * - - - - -
EV-C99-A (5) EV-C99-B/C (19) *** *** *** *** ** ***
EV-C99-A (5) EV-C99-B (8) *** *** *** *** *** ***
EV-C99-A (5) EV-C99-C (10) *** ** * - - -
EV-C99-B (8) EV-C99-C (10) - - - - - -
CVA-24 (22) CVA-24v (20) - ** *** - - -
CVA-24-A (2) CVA-24-B (4) - - - - - -
CVA-24-A (2) CVA-24-C (2) - - - - - -
CVA-24-A (2) CVA-24-D (9) - - - - - -
CVA-24-A (2) CVA-24-E (2) - - - - - -
CVA-24-A (2) CVA-24-F (2) - - - - - -
CVA-24-A (2) CVA-24v (20) - - - - - *
CVA-24-B (4) CVA-24-C (2) - - - - - -
CVA-24-B (4) CVA-24-D (9) - - - * - *
CVA-24-B (4) CVA-24-E (2) - - - - - -
CVA-24-B (4) CVA-24-F (2) - - - - - -
CVA-24-B (4) CVA-24v (20) - - - - - *
CVA-24-C (2) CVA-24-D (9) - - - - - *
CVA-24-C (2) CVA-24-E (2) - - - - - -
CVA-24-C (2) CVA-24-F (2) - - - - - -
CVA-24-C (2) CVA-24v (20) - - - - - -
CVA-24-D (9) CVA-24-E (2) - * * - - -
CVA-24-D (9) CVA-24-F (2) - - - - - -
CVA-24-D (9) CVA-24v (20) * * ** - - -
CVA-24-E (2) CVA-24-F (2) - - - - - -
CVA-24-E (2) CVA-24v (20) - - - - - *
CVA-24-F (2) CVA-24v (20) ** - * ** - **
CVA-24-A (2) CVA-24-B-F/v (40) - - ** - - -
CVA-24-B/C (6) CVA-24-D-F/v (35) - - - - - *
CVA-24-D-F (15) CVA-24v (20) - - * - - -
Statistical significance for higher than expected proportion of fixed non-synonymous substitutions (i.e. nF/nP .. sF/sP) between different clusters is shown. P-values
were calculated using chi-squared test. (* 0.05.P.0.01; ** 0.01.P.0.001; *** P,0.001; - not significant).
doi:10.1371/journal.pone.0093737.t004
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General aspects of molecular evolution and
epidemiology of CVA-21, CVA-24, EV-C96 and EV-C99
Altogether 72 strains of EV-C sub-group B were sequenced in
this study. Most of the strains were isolated in Finland during
routine entero/poliovirus surveillance [23]. Previous reports have
suggested low prevalence of EV-C viruses in temperate regions,
whereas in tropical and sub-tropical regions EV-C viruses are
highly prevalent [17,18,48–51]. In this study, EV-C strains were
found regularly in Finland. However, in most cases the possibility
of travel-related importation from tropical or sub-tropical regions
cannot be excluded. Therefore, on the basis of this study it cannot
be stated unambiguously whether the EV-C strains are capable of
wide circulation in Finland. The majority of the strains showed no
evidence of geographic or temporal clustering, suggesting no
evidence for EV-C outbreaks in Finland. Although some lineages
of EV-C99 and CVA-24 were detected during several years in
Finland, repeated introduction from other countries cannot be
excluded.
The mean nucleotide substitution rates of EV-C sub-group B
(ranging from 1.170 to 3.62561023 with combined HPD interval
of 1.170 to 3.625 for partial VP1) estimated using Bayesian
MCMC method were slightly lower than the corresponding
estimates for other enterovirus types (ranging from 4.2 to
8.661023 for complete VP1 and 4.8 to 1261023 for partial
VP1) [52–63]. Previously, similar low substitution rate has been
estimated for partial VP1 coding region of CVA-24v strains using
linear regression [64]. Correspondingly, the estimated tMRCAs of
EV-C sub-group B dated earlier than those estimated for most
other EV-types. Previously, correlation between the epidemiolog-
ical fitness and higher mutation, genome replication and
nucleotide substitution rates has been found with noroviruses
[65]. Further studies should be conducted to assess if such
correlation also applies for enteroviruses. However, it should be
noted that the molecular clock analysis contains several limitations.
For some of the types (e.g. EV-C96), only recently isolated strains
are available. The estimated tMRCAs of the more distant
ancestors of different EV-types (i.e. the deep nodes in the
phylogenetic tree) are therefore highly unreliable since sequence
data is available only from the most recent few decades. Likewise,
the datasets analysed are likely to be biased due to sparse sampling
and (both temporally and geographically) uneven sampling
frequencies. Therefore, more sequence data, possibly from
archived samples, would be needed to confirm the apparently
lower rate of evolution in this EV-C sub-group.
Evolutionary patterns within and between types
Each of the enterovirus types analysed in this study had
relatively high intra-typic sequence diversities in VP1 (approaching
the ,25% nt divergence limit for grouping into the same type).
The phylogenetic analysis of nucleotide sequences suggested
robust grouping into intra-typic genotypes within each type.
Within each type the vast majority of nucleotide substitutions were
synonymous and the non-synonymous substitutions (i.e. amino
acid substitutions) tended to cluster at distinct highly polymorphic
sites. Signs of positive selection were detected in some of these
highly polymorphic sites, while strong negative selection was
indicated in most of the codons of VP1. Despite robust clustering
to intra-typic genotypes, only few genotype-specific ‘signature’
amino acids were detected between these intra-typic clusters,
whereas several amino acid sites showed evidence of parallel
evolution (i.e. similar amino acid substitutions had apparently
occurred independently in different genetic lineages).
In contrast, when different types were compared, the McDonald-
Kreitman tests suggested a clear tendency towards fixation of type-
specific ‘signature’ amino acids. Furthermore, several type-specific
insertions/deletions were detected and the locations of highly
polymorphic or positively selected amino acid sites overlapped
only partially between different types. These results suggest that
permanent fixation of type-specific amino acids seems to be a
hallmark associated with evolution of different enterovirus types,
whereas neutral evolution and/or (most likely frequency-depen-
dent, see below) positive selection in few highly polymorphic
amino acid sites were the dominant forms of evolution when
strains within a type were compared. An exception to the rarity of
permanently fixed signature amino acids in most intra-typic
lineages was EV-C99 genotype A that showed similar differences
(i.e. fixation of ‘signature’ amino acids and insertion/deletion sites)
to those detected in inter-typic comparisons. The strains of EV-
C99 genotype A also had relatively low pairwise similarities (a
minimum of 73.1% nucleotide and 86.1% amino acid similarity)
with some of the strains of EV-C99 genotypes B and C. Curiously,
EV-C99 groups A and B/C may also have antigenic differences
since the strains of genotype A show cross-neutralization with the
antibodies raised against CVA-24-Joseph whereas the strains of
EV-C99 group B do not show such cross-neutralization [5].
Therefore, the EV-C99 genotypes A and B/C may be under a
process of divergent evolution that might ultimately lead to two
distinct virus types. Further complete genome sequencing is
needed to evaluate whether the strains of EV-C99 genotype A are
divergent enough to merit classification to a separate type.
The different evolutionary patterns within and between EV
types may also have implication on the genetic classification of
enteroviruses. In the current classification scheme, EV-strains are
classified into the same type, if they have more than 75%
nucleotide and more than 85% (or 88%) amino acid similarities in
the VP1 region and into different types, if the strains that have less
than 70% nucleotide and 85% amino acid similarities [3,5].
However, divergent strains that have pairwise nt/aa similarities in
the ‘grey-zone’ of current typing (i.e. 70–75% nt and/or 85–88%
aa similarity) are detected regularly. The hallmarks of inter-typic
comparisons (fixation of type-specific amino acids and insertion/
deletion sites) could be applied as an additional classification
criterion in such cases. In this study, EV-C99 and CVA-24 were
clearly separated on the basis of MK-tests despite the ‘grey-zone’
nucleotide/amino acid similarities between these types. However,
further studies on other enterovirus species should be conducted to
study the universality of these potential novel classification criteria
first.
Possible structural constraints in intra-typic evolution
Within each EV-type analysed, most of the codons in VP1 were
detected to be under negative selection. This suggests a strong
evolutionary pressure to retain the amino acid sequence and, thus,
the structure of VP1. On the basis of the structure of CVA-21
[42], the highly polymorphic amino acid sites are most likely
located in the loops between beta-sheets and the structurally
disordered amino- and carboxyl-terminal segments of VP1. Such
pattern may be explained by frequency-dependent selection (a rare
variant has greater fitness than a common variant) posed by the
host immune system to amino acids at the virus surface (e.g.,
antigenic sites). While a mutation at antigenic site could allow the
virus to escape from the host immune response, due to the
adaptability of the host immune system, the advantage could be
short term. At the virus type-level, this changing selective pressure
could result in a highly polymorphic site. Alternatively, neutral
amino acid substitutions located in the surface loops or amino- and
carboxy-terminal segments may have remained in the virus
population due to genetic drift.
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Similar results (i.e. high proportion of negatively selected codons
combined with neutral evolution and/or evidence of positive
selection in few codons) have been detected also for other EV-
types including PV [66–68], E-30 [69], EV-71 [56], CVA-4 [58],
E-6 [57] and CVB-5 [61]. These results suggest that the intra-typic
evolution of the VP1 protein is most likely dominated by (mostly
neutral) synonymous mutations combined with frequency-depen-
dent selection and/or neutral evolution at antigenic sites. Intra-
typic lineages would therefore have similar structural constraints
with variation occurring predominantly at specific sites.
Interestingly, the AHC-causing CVA-24v strains showed less
amino acid diversity in VP1 than the other CVA-24 strains.
Furthermore, the amino acid polymorphisms were located in
different sites in CVA-24v compared to the non-AHC-causing
CVA-24 strains. The AHC-causing variants of CVA-24 emerged
in Singapore in the year 1970 [21]. Both epidemiological and
phylogenetic studies suggest a single origin for CVA-24v strains
[5,21]. Therefore, it is likely that CVA-24v strains have undergone
a strict population bottle-neck during the colonisation of a new
target tissue (i.e. conjunctiva). The high degree of amino acid
conservation between CVA-24v strains may be due to this
population bottle-neck. Alternatively, CVA-24v strains might be
under more strict negative selection than the other CVA-24
lineages. However, the overall dN/dS values were similar for both
CVA-24v and the non-AHC-causing CVA-24 genotypes suggest-
ing similar strength of negative selection for both groups.In
contrast to the intra-typic evolution, the inter-typic comparisons
between EV-C96, CVA-21, EV-99 and CVA-24 suggest that mere
frequency-dependent selection in antigenic sites is not sufficient to
explain the differences between the EV types. Apparently, the
evolution leading to a formation of a new enterovirus type has
included permanent fixation and insertion/deletion of distinct
amino acids. Furthermore, the polymorphic sites overlap only
partially between different EV types. These observations suggest
that, in addition to amino acid changes at antigenic sites, also
structural changes may have occurred during divergent evolution
of EV-types. Hypothetically, a structural change could expose new
amino acid sites to selective pressure imposed by the host immune
system and, on the other hand, require fixation at sites where
polymorphism was previously allowed. Furthermore, an (fitness
decreasing) amino acid mutation may require compensatory
amino acid fixation(s) elsewhere in the capsid protein.
Alternatively, fixation of neutral amino acid substitutions may
have occurred in the ancestral populations of EV-types due to
genetic drift during population bottle-necks. However, although
the estimated tMRCAs of the more distant ancestors of different
EV-types (i.e. the deep nodes in the phylogenetic tree) are highly
unreliable, it is likely that the type-specific amino acids have
remained conserved for hundreds of years. This suggests strong
selection pressures favouring these type-specific amino acids in the
given genetic context. Therefore, it is more likely that the
permanent fixation of type-specific amino acids is due to dissimilar
selection pressures subjected to the ancestor lineages of different
enterovirus types. Further studies are needed to elucidate the
processes leading to fixation of type-specific amino acid substitu-
tions.
Concluding remarks
The sequence analysis presented in this article suggests different
modes of evolution within enterovirus types (resulting in intra-typic
lineages) and during evolution, which leads to larger scale (type-
specific) differences. In this respect, intra-typic genetic change
would be dominated by silent mutations accompanied by amino
acid polymorphism occurring dominantly at immunogenic sites.
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This genetic change can be observed as a high rate of synonymous
mutations, strong negative selection and amino acid polymor-
phism and/or positive selection at distinct sites in structurally
disordered regions. Inter-typic differences, on the other hand,
included permanent fixation and insertion/deletion of distinct
‘signature’-amino acids that could be a result of larger scale
changes in the capsid structure.
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